Extraordinary Complication of COVID-19 Swab Testing: CSF Rhinorrhea

dc.contributor.authorUz, U
dc.contributor.authorGuenhan, K
dc.contributor.authorPabuscu, Y
dc.contributor.authorMutlu, S
dc.contributor.authorKamiloglu, U
dc.date.accessioned2025-04-10T10:27:06Z
dc.date.available2025-04-10T10:27:06Z
dc.description.abstractCoronavirus disease 2019 (COVID-19) is a highly contagious disease that has reached pandemic status. The diagnosis of COVID-19 is made using the polymerase chain reaction test to evaluate a swab taken from the naso/oro-pharyngeal area. Since COVID-19 is still a pandemic, it is thought that the use of this diagnostic test will be on the agenda for a while. A patient with COVID-19 symptoms presented with unilateral cerebrospinal fluid rhinorrhea after a nasopharyngeal swab test. Although nasopharyngeal swabs are taken very frequently, the complication rate is very low. However, life-threatening complications can be observed on rare occasions, and care should be taken.
dc.identifier.e-issn1536-3732
dc.identifier.issn1049-2275
dc.identifier.urihttp://hdl.handle.net/20.500.14701/34669
dc.language.isoEnglish
dc.titleExtraordinary Complication of COVID-19 Swab Testing: CSF Rhinorrhea
dc.typeArticle

Files